SE529906C2 - Use of composition comprising pentane-1,5-diol to reduce and/or eliminate odor obtained from urine, faeces, liquids from leg ulcers, decubital ulcers, blood, menstruation and perspiration - Google Patents
Use of composition comprising pentane-1,5-diol to reduce and/or eliminate odor obtained from urine, faeces, liquids from leg ulcers, decubital ulcers, blood, menstruation and perspirationInfo
- Publication number
- SE529906C2 SE529906C2 SE0502610A SE0502610A SE529906C2 SE 529906 C2 SE529906 C2 SE 529906C2 SE 0502610 A SE0502610 A SE 0502610A SE 0502610 A SE0502610 A SE 0502610A SE 529906 C2 SE529906 C2 SE 529906C2
- Authority
- SE
- Sweden
- Prior art keywords
- diol
- urine
- pentane
- menstruation
- ulcers
- Prior art date
Links
- 210000002700 urine Anatomy 0.000 title claims abstract description 15
- ALQSHHUCVQOPAS-UHFFFAOYSA-N Pentane-1,5-diol Chemical compound OCCCCCO ALQSHHUCVQOPAS-UHFFFAOYSA-N 0.000 title claims abstract description 9
- 239000008280 blood Substances 0.000 title claims abstract description 9
- 210000004369 blood Anatomy 0.000 title claims abstract description 9
- 210000003608 fece Anatomy 0.000 title claims abstract description 9
- 230000005906 menstruation Effects 0.000 title claims abstract description 9
- 208000005230 Leg Ulcer Diseases 0.000 title claims abstract description 8
- 239000000203 mixture Substances 0.000 title claims abstract description 8
- 208000025865 Ulcer Diseases 0.000 title claims abstract 4
- 231100000397 ulcer Toxicity 0.000 title claims abstract 4
- 239000007788 liquid Substances 0.000 title abstract 2
- 229940121375 antifungal agent Drugs 0.000 claims abstract description 6
- 230000000844 anti-bacterial effect Effects 0.000 claims abstract description 4
- 230000000843 anti-fungal effect Effects 0.000 claims abstract description 4
- 238000004519 manufacturing process Methods 0.000 claims abstract description 4
- 239000002250 absorbent Substances 0.000 claims description 16
- 230000002745 absorbent Effects 0.000 claims description 16
- 239000012530 fluid Substances 0.000 claims description 10
- 206010052428 Wound Diseases 0.000 claims description 8
- 208000027418 Wounds and injury Diseases 0.000 claims description 8
- 210000004243 sweat Anatomy 0.000 claims description 5
- 206010021639 Incontinence Diseases 0.000 claims description 4
- 239000000853 adhesive Substances 0.000 claims description 3
- 239000003443 antiviral agent Substances 0.000 claims description 3
- 239000003795 chemical substances by application Substances 0.000 claims description 2
- 238000009472 formulation Methods 0.000 claims description 2
- 239000007921 spray Substances 0.000 claims description 2
- 230000001815 facial effect Effects 0.000 claims 1
- 241000124008 Mammalia Species 0.000 abstract description 5
- 238000010521 absorption reaction Methods 0.000 abstract 3
- 230000000694 effects Effects 0.000 abstract 1
- 230000010534 mechanism of action Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 150000002009 diols Chemical class 0.000 description 50
- 235000019645 odor Nutrition 0.000 description 13
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 4
- SVTBMSDMJJWYQN-UHFFFAOYSA-N 2-methylpentane-2,4-diol Chemical compound CC(O)CC(C)(C)O SVTBMSDMJJWYQN-UHFFFAOYSA-N 0.000 description 4
- BTVWZWFKMIUSGS-UHFFFAOYSA-N 2-methylpropane-1,2-diol Chemical compound CC(C)(O)CO BTVWZWFKMIUSGS-UHFFFAOYSA-N 0.000 description 4
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 4
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 4
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 4
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 4
- 210000001124 body fluid Anatomy 0.000 description 4
- 239000010839 body fluid Substances 0.000 description 4
- WERYXYBDKMZEQL-UHFFFAOYSA-N butane-1,4-diol Chemical compound OCCCCO WERYXYBDKMZEQL-UHFFFAOYSA-N 0.000 description 4
- YPFDHNVEDLHUCE-UHFFFAOYSA-N propane-1,3-diol Chemical compound OCCCO YPFDHNVEDLHUCE-UHFFFAOYSA-N 0.000 description 4
- 125000004432 carbon atom Chemical group C* 0.000 description 3
- -1 heptane-2,3-diol diol Chemical compound 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- DCTMXCOHGKSXIZ-UHFFFAOYSA-N (R)-1,3-Octanediol Chemical compound CCCCCC(O)CCO DCTMXCOHGKSXIZ-UHFFFAOYSA-N 0.000 description 2
- VAZJLPXFVQHDFB-UHFFFAOYSA-N 1-(diaminomethylidene)-2-hexylguanidine Polymers CCCCCCN=C(N)N=C(N)N VAZJLPXFVQHDFB-UHFFFAOYSA-N 0.000 description 2
- QWGRWMMWNDWRQN-UHFFFAOYSA-N 2-methylpropane-1,3-diol Chemical compound OCC(C)CO QWGRWMMWNDWRQN-UHFFFAOYSA-N 0.000 description 2
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 2
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 description 2
- 229940123208 Biguanide Drugs 0.000 description 2
- 239000004358 Butane-1, 3-diol Substances 0.000 description 2
- 229930186147 Cephalosporin Natural products 0.000 description 2
- GHXZTYHSJHQHIJ-UHFFFAOYSA-N Chlorhexidine Chemical compound C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 GHXZTYHSJHQHIJ-UHFFFAOYSA-N 0.000 description 2
- 241000207199 Citrus Species 0.000 description 2
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 2
- 102000002068 Glycopeptides Human genes 0.000 description 2
- 108010015899 Glycopeptides Proteins 0.000 description 2
- 241000220225 Malus Species 0.000 description 2
- JNTOCHDNEULJHD-UHFFFAOYSA-N Penciclovir Chemical compound N1C(N)=NC(=O)C2=C1N(CCC(CO)CO)C=N2 JNTOCHDNEULJHD-UHFFFAOYSA-N 0.000 description 2
- 229930182555 Penicillin Natural products 0.000 description 2
- 229920002413 Polyhexanide Polymers 0.000 description 2
- 239000004146 Propane-1,2-diol Substances 0.000 description 2
- 241000220317 Rosa Species 0.000 description 2
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 2
- 239000004098 Tetracycline Substances 0.000 description 2
- MKUXAQIIEYXACX-UHFFFAOYSA-N aciclovir Chemical compound N1C(N)=NC(=O)C2=C1N(COCCO)C=N2 MKUXAQIIEYXACX-UHFFFAOYSA-N 0.000 description 2
- 229960004150 aciclovir Drugs 0.000 description 2
- 229940072056 alginate Drugs 0.000 description 2
- 235000010443 alginic acid Nutrition 0.000 description 2
- 229920000615 alginic acid Polymers 0.000 description 2
- 229940126575 aminoglycoside Drugs 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 230000002421 anti-septic effect Effects 0.000 description 2
- 230000000840 anti-viral effect Effects 0.000 description 2
- 229940088710 antibiotic agent Drugs 0.000 description 2
- 229940064004 antiseptic throat preparations Drugs 0.000 description 2
- 125000004429 atom Chemical group 0.000 description 2
- 150000004283 biguanides Chemical class 0.000 description 2
- BMRWNKZVCUKKSR-UHFFFAOYSA-N butane-1,2-diol Chemical compound CCC(O)CO BMRWNKZVCUKKSR-UHFFFAOYSA-N 0.000 description 2
- 235000019437 butane-1,3-diol Nutrition 0.000 description 2
- 229940041011 carbapenems Drugs 0.000 description 2
- 229940124587 cephalosporin Drugs 0.000 description 2
- 150000001780 cephalosporins Chemical class 0.000 description 2
- 229960003260 chlorhexidine Drugs 0.000 description 2
- 235000020971 citrus fruits Nutrition 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 229910052802 copper Inorganic materials 0.000 description 2
- 229940108928 copper Drugs 0.000 description 2
- 239000010949 copper Substances 0.000 description 2
- 229940124307 fluoroquinolone Drugs 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- GCXZDAKFJKCPGK-UHFFFAOYSA-N heptane-1,2-diol Chemical compound CCCCCC(O)CO GCXZDAKFJKCPGK-UHFFFAOYSA-N 0.000 description 2
- HTXVEEVTGGCUNC-UHFFFAOYSA-N heptane-1,3-diol Chemical compound CCCCC(O)CCO HTXVEEVTGGCUNC-UHFFFAOYSA-N 0.000 description 2
- OGRCRHSHBFQRKO-UHFFFAOYSA-N heptane-1,4-diol Chemical compound CCCC(O)CCCO OGRCRHSHBFQRKO-UHFFFAOYSA-N 0.000 description 2
- NNYOSLMHXUVJJH-UHFFFAOYSA-N heptane-1,5-diol Chemical compound CCC(O)CCCCO NNYOSLMHXUVJJH-UHFFFAOYSA-N 0.000 description 2
- UQGLNXPQGUMNRU-UHFFFAOYSA-N heptane-1,6-diol Chemical compound CC(O)CCCCCO UQGLNXPQGUMNRU-UHFFFAOYSA-N 0.000 description 2
- SXCBDZAEHILGLM-UHFFFAOYSA-N heptane-1,7-diol Chemical compound OCCCCCCCO SXCBDZAEHILGLM-UHFFFAOYSA-N 0.000 description 2
- XVEOUOTUJBYHNL-UHFFFAOYSA-N heptane-2,4-diol Chemical compound CCCC(O)CC(C)O XVEOUOTUJBYHNL-UHFFFAOYSA-N 0.000 description 2
- XTVHTJKQKUOEQA-UHFFFAOYSA-N heptane-2,5-diol Chemical compound CCC(O)CCC(C)O XTVHTJKQKUOEQA-UHFFFAOYSA-N 0.000 description 2
- OZIMXLFSRSPFAS-UHFFFAOYSA-N heptane-2,6-diol Chemical compound CC(O)CCCC(C)O OZIMXLFSRSPFAS-UHFFFAOYSA-N 0.000 description 2
- ZNZZFXONMYVVGZ-UHFFFAOYSA-N heptane-3,4-diol Chemical compound CCCC(O)C(O)CC ZNZZFXONMYVVGZ-UHFFFAOYSA-N 0.000 description 2
- BQWORYKVVNTRAW-UHFFFAOYSA-N heptane-3,5-diol Chemical compound CCC(O)CC(O)CC BQWORYKVVNTRAW-UHFFFAOYSA-N 0.000 description 2
- FHKSXSQHXQEMOK-UHFFFAOYSA-N hexane-1,2-diol Chemical compound CCCCC(O)CO FHKSXSQHXQEMOK-UHFFFAOYSA-N 0.000 description 2
- AVIYEYCFMVPYST-UHFFFAOYSA-N hexane-1,3-diol Chemical compound CCCC(O)CCO AVIYEYCFMVPYST-UHFFFAOYSA-N 0.000 description 2
- QVTWBMUAJHVAIJ-UHFFFAOYSA-N hexane-1,4-diol Chemical compound CCC(O)CCCO QVTWBMUAJHVAIJ-UHFFFAOYSA-N 0.000 description 2
- XXMIOPMDWAUFGU-UHFFFAOYSA-N hexane-1,6-diol Chemical compound OCCCCCCO XXMIOPMDWAUFGU-UHFFFAOYSA-N 0.000 description 2
- QCIYAEYRVFUFAP-UHFFFAOYSA-N hexane-2,3-diol Chemical compound CCCC(O)C(C)O QCIYAEYRVFUFAP-UHFFFAOYSA-N 0.000 description 2
- TXGJTWACJNYNOJ-UHFFFAOYSA-N hexane-2,4-diol Chemical compound CCC(O)CC(C)O TXGJTWACJNYNOJ-UHFFFAOYSA-N 0.000 description 2
- OHMBHFSEKCCCBW-UHFFFAOYSA-N hexane-2,5-diol Chemical compound CC(O)CCC(C)O OHMBHFSEKCCCBW-UHFFFAOYSA-N 0.000 description 2
- POFSNPPXJUQANW-UHFFFAOYSA-N hexane-3,4-diol Chemical compound CCC(O)C(O)CC POFSNPPXJUQANW-UHFFFAOYSA-N 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- 150000002460 imidazoles Chemical class 0.000 description 2
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 2
- 239000003120 macrolide antibiotic agent Substances 0.000 description 2
- 229940041033 macrolides Drugs 0.000 description 2
- 229940041009 monobactams Drugs 0.000 description 2
- AEIJTFQOBWATKX-UHFFFAOYSA-N octane-1,2-diol Chemical compound CCCCCCC(O)CO AEIJTFQOBWATKX-UHFFFAOYSA-N 0.000 description 2
- NELAVKWPGRMFEQ-UHFFFAOYSA-N octane-1,4-diol Chemical compound CCCCC(O)CCCO NELAVKWPGRMFEQ-UHFFFAOYSA-N 0.000 description 2
- ZKRNQSNKDPEUOH-UHFFFAOYSA-N octane-1,5-diol Chemical compound CCCC(O)CCCCO ZKRNQSNKDPEUOH-UHFFFAOYSA-N 0.000 description 2
- GDUWKVCUIFEAGC-UHFFFAOYSA-N octane-1,6-diol Chemical compound CCC(O)CCCCCO GDUWKVCUIFEAGC-UHFFFAOYSA-N 0.000 description 2
- QUADBKCRXGFGAX-UHFFFAOYSA-N octane-1,7-diol Chemical compound CC(O)CCCCCCO QUADBKCRXGFGAX-UHFFFAOYSA-N 0.000 description 2
- OEIJHBUUFURJLI-UHFFFAOYSA-N octane-1,8-diol Chemical compound OCCCCCCCCO OEIJHBUUFURJLI-UHFFFAOYSA-N 0.000 description 2
- XMTUJCWABCYSIV-UHFFFAOYSA-N octane-2,3-diol Chemical compound CCCCCC(O)C(C)O XMTUJCWABCYSIV-UHFFFAOYSA-N 0.000 description 2
- HOWLAKMIIWUJEJ-UHFFFAOYSA-N octane-2,4-diol Chemical compound CCCCC(O)CC(C)O HOWLAKMIIWUJEJ-UHFFFAOYSA-N 0.000 description 2
- AZVKGHXATHHFRF-UHFFFAOYSA-N octane-2,5-diol Chemical compound CCCC(O)CCC(C)O AZVKGHXATHHFRF-UHFFFAOYSA-N 0.000 description 2
- ONGUKKAIGDNAGC-UHFFFAOYSA-N octane-2,6-diol Chemical compound CCC(O)CCCC(C)O ONGUKKAIGDNAGC-UHFFFAOYSA-N 0.000 description 2
- PAXWQLGKYISPNH-UHFFFAOYSA-N octane-2,7-diol Chemical compound CC(O)CCCCC(C)O PAXWQLGKYISPNH-UHFFFAOYSA-N 0.000 description 2
- UJWVPVVMYOBBIY-UHFFFAOYSA-N octane-3,4-diol Chemical compound CCCCC(O)C(O)CC UJWVPVVMYOBBIY-UHFFFAOYSA-N 0.000 description 2
- WYNVIVRXHYGNRT-UHFFFAOYSA-N octane-3,5-diol Chemical compound CCCC(O)CC(O)CC WYNVIVRXHYGNRT-UHFFFAOYSA-N 0.000 description 2
- BCKOQWWRTRBSGR-UHFFFAOYSA-N octane-3,6-diol Chemical compound CCC(O)CCC(O)CC BCKOQWWRTRBSGR-UHFFFAOYSA-N 0.000 description 2
- 150000002960 penicillins Chemical class 0.000 description 2
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 description 2
- RUOPINZRYMFPBF-UHFFFAOYSA-N pentane-1,3-diol Chemical compound CCC(O)CCO RUOPINZRYMFPBF-UHFFFAOYSA-N 0.000 description 2
- GLOBUAZSRIOKLN-UHFFFAOYSA-N pentane-1,4-diol Chemical compound CC(O)CCCO GLOBUAZSRIOKLN-UHFFFAOYSA-N 0.000 description 2
- XLMFDCKSFJWJTP-UHFFFAOYSA-N pentane-2,3-diol Chemical compound CCC(O)C(C)O XLMFDCKSFJWJTP-UHFFFAOYSA-N 0.000 description 2
- GTCCGKPBSJZVRZ-UHFFFAOYSA-N pentane-2,4-diol Chemical compound CC(O)CC(C)O GTCCGKPBSJZVRZ-UHFFFAOYSA-N 0.000 description 2
- 239000002304 perfume Substances 0.000 description 2
- 229940093158 polyhexanide Drugs 0.000 description 2
- 229960004063 propylene glycol Drugs 0.000 description 2
- 235000013772 propylene glycol Nutrition 0.000 description 2
- 150000007660 quinolones Chemical class 0.000 description 2
- 229910052709 silver Inorganic materials 0.000 description 2
- 229940009188 silver Drugs 0.000 description 2
- 239000004332 silver Substances 0.000 description 2
- 230000035900 sweating Effects 0.000 description 2
- 235000019364 tetracycline Nutrition 0.000 description 2
- 150000003522 tetracyclines Chemical class 0.000 description 2
- 229940040944 tetracyclines Drugs 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 239000011701 zinc Substances 0.000 description 2
- 229910052725 zinc Inorganic materials 0.000 description 2
- 239000011787 zinc oxide Substances 0.000 description 2
- 229960001296 zinc oxide Drugs 0.000 description 2
- UNVGBIALRHLALK-UHFFFAOYSA-N 1,5-Hexanediol Chemical compound CC(O)CCCCO UNVGBIALRHLALK-UHFFFAOYSA-N 0.000 description 1
- 101100126625 Caenorhabditis elegans itr-1 gene Proteins 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 239000002386 air freshener Substances 0.000 description 1
- 239000002781 deodorant agent Substances 0.000 description 1
- VUVZASHBYYMLRC-UHFFFAOYSA-N heptane-2,3-diol Chemical compound CCCCC(O)C(C)O VUVZASHBYYMLRC-UHFFFAOYSA-N 0.000 description 1
- TVMXDCGIABBOFY-UHFFFAOYSA-N octane Chemical compound CCCCCCCC TVMXDCGIABBOFY-UHFFFAOYSA-N 0.000 description 1
- YOEZZCLQJVMZGY-UHFFFAOYSA-N octane-4,5-diol Chemical compound CCCC(O)C(O)CCC YOEZZCLQJVMZGY-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/20—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing organic materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/46—Deodorants or malodour counteractants, e.g. to inhibit the formation of ammonia or bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L9/00—Disinfection, sterilisation or deodorisation of air
- A61L9/01—Deodorant compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L9/00—Disinfection, sterilisation or deodorisation of air
- A61L9/14—Disinfection, sterilisation or deodorisation of air using sprayed or atomised substances including air-liquid contact processes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q15/00—Anti-perspirants or body deodorants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q90/00—Cosmetics or similar toiletry preparations for specific uses not provided for in other groups of this subclass
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Materials Engineering (AREA)
- Hematology (AREA)
- Emergency Medicine (AREA)
- Birds (AREA)
- Cosmetics (AREA)
- Absorbent Articles And Supports Therefor (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Orthopedics, Nursing, And Contraception (AREA)
- Disinfection, Sterilisation Or Deodorisation Of Air (AREA)
Abstract
Description
25 30 529 906 071002 AEK P:\5695 Ambria\P\014\SE\Svar på slutfórelåggande\P56950014_071002_Patent.doc läckage av exempelvis urin eller svettning, liksom att kostnaderna skulle kunna minskas för användaren då det inte skulle vara lika stort behov av att byta produkten lika ofta. Därför finns det ett behov av nya engångsprodukter som uppfyller behovet av att minska och/eller eliminera odören från vätskor från människor, och därmed minska kostnaderna såväl som trycket på miljön från engångs- artiklar. 25 30 529 906 071002 AEK P: \ 5695 Ambria \ P \ 014 \ SE \ Response to final proposal \ P56950014_071002_Patent.doc leakage of eg urine or sweating, as well as that the costs could be reduced for the user as there would not be as great a need to change the product as often. Therefore, there is a need for new disposable products that meet the need to reduce and / or eliminate odors from human fluids, thereby reducing costs as well as the pressure on the environment from disposable items.
SAMMANFATTNING AV UPPFINNINGEN Uppfinningen hänför sig till användningen av en beredning innefattande pentan-1,5-diol, för att minska och/eller eliminera odör från ett däggdjur, såsom urin, feces, vätskor från bensår, dekubitala sàr, blod och svett.SUMMARY OF THE INVENTION The invention relates to the use of a preparation comprising pentane-1,5-diol, for reducing and / or eliminating odor from a mammal, such as urine, faeces, fluids from leg ulcers, decubital wounds, blood and sweat.
Genom uppfinningen lider inte användaren av beredningen av odören som kroppsvätskor från människor normalt ger upphov till. Beredningen kan finnas integrerad/ anbringad på ett absorbent och/eller en sanitetsartikel, och därmed minska och/eller eliminera odören från dägg- djuret vid användning av nämnda artikel.The invention does not suffer the user of the preparation of the odor which body fluids from humans normally give rise to. The preparation can be integrated / applied to an absorbent and / or a sanitary article, and thereby reduce and / or eliminate the odor from the mammal when using said article.
Uppfinningen hänför sig också till förpackningar som omfattar en eller flera absorbenter och/eller sanitets- artiklar såsom de nämnts ovan.The invention also relates to packages comprising one or more absorbents and / or sanitary articles as mentioned above.
Genom det uppfunna användandet att använda åtminstone en diol för att minska och/eller eliminera odör har ett flertal problem lösts, såsom att användaren inte lider av odör, och det finns inget behov av att byta ut t.ex. en binda frekvent, och därmed minskar kostnaden för an- vändandet av bindorna.Through the invented use of using at least one diol to reduce and / or eliminate odor, a number of problems have been solved, such as that the user does not suffer from odor, and there is no need to replace e.g. a napkin frequently, thus reducing the cost of using the napkins.
DETALJERAD BESKRIVNING AV UPPFINNINGEN I föreliggande uppfinnings sammanhang tillämpas följande definitioner: 10 15 20 25 30 35 529 906 071002 ÄEK P:\569S Ambria\P\0l4\SE\SVar på Slutfäre1åggflnde\1>5695001~l_0'71002_Patent.dOC Termerna ”artikel” och ”produkt” i ansökan är avsedda att mena detsamma.DETAILED DESCRIPTION OF THE INVENTION In the context of the present invention, the following definitions are applied: 10 15 20 25 30 35 529 906 071002 ÄEK P: \ 569S Ambria \ P \ 0l4 \ SE \ SVs "And" product "in the application are intended to mean the same.
Termen ”odör” är avsedd att betyda en odör som kan uppstå från kroppsvätskor från däggdjur såsom en människa.The term "odor" is intended to mean an odor that can arise from body fluids from mammals such as a human.
Exempel på kroppsvätskor är urin, feces, vätskor från dekubitala sår, blod, Termen ”absorberande produkt” är ämnad att betyda en produkt som kan absorbera kroppsvätskor, eller kompresser. bensàr, svett och menstruation. såsom bandage Termen ”sanitetsprodukt” är ämnad att betyda en produkt som kan användas för att absorbera urin, och/eller menstruation. Exempel är spray och deodoranter.Examples of body fluids are urine, faeces, fluids from decubital wounds, blood. The term "absorbent product" is intended to mean a product that can absorb body fluids, or compresses. leg ulcers, sweating and menstruation. as a bandage The term "sanitary product" is intended to mean a product that can be used to absorb urine, and / or menstruation. Examples are sprays and deodorants.
Användning av en diol för att minska odör Uppfinningen hänför sig till användningen av en beredningen omfattande åtminstone en diol för att minska och/eller eliminera odör från ett däggdjur, såsom odör från urin, feces, vätskor från bensår, dekubitala sår, blod, menstruation och svett. Diolen kan ha en generell struktur på (CH2)nH2O2, vari n representerar antalet CH2. T.ex. kan n vara från 3 till 10, såsom 3, 4, 5, 6, 7, 8, 9 eller 10.The invention relates to the use of a preparation comprising at least one diol for reducing and / or eliminating odor from a mammal, such as odor from urine, faeces, fluids from leg ulcers, decubital wounds, blood, menstruation and sweat. The diol may have a general structure of (CH2) nH2O2, where n represents the number of CH2. For example. n can be from 3 to 10, such as 3, 4, 5, 6, 7, 8, 9 or 10.
Vidare kan diolerna ha en hydroxylgrupp på en av diolerna, som är kopplad till olika kolatomer. Exempel på dioler är propan~l,2-diol, propan-1,3-diol, butan-1,2-diol, butan-1,3-diol, butan-1,4-diol, 2-metylpropan-1,2-diol, 2- metylpropan-l,3-diol, pentan-1,2-diol, pentan-1,3-diol, pentan-1,4-diol, pentan-l,5-diol, 2~metyl-pentan-2,4-diol, pentan-2,3~diol, pentan-2,4-diol, hexan-1,2-diol, hexan- l,3~diol, hexan-1,4-diol, hexan~l,5-diol, hexan-1,6-diol, hexan-2,3-diol, hexan-2,4-diol, hexan-2,5~diol, hexan~3,4- diol, heptan-1,2-diol, heptan-1,3-diol, heptan~l,4-diol, heptan-l,5-diol, heptan-1,6-diol, heptan-l,7~diol, heptan- 2,3~diol, heptan-2,4~diol, heptan-2,5~diol, heptan-2,6- diol, heptan-3,4-diol, heptan-3,5-diol, oktan-l,2-diol, 10 15 20 25 30 35 529 906 071002 AEK 1==\ss9s mnbria\s\oia\sz\svar på slucförelaggande\z>5s9soo14_o71oo2_1=acent.dec 4 oktan-1,3-diol, oktan-1,4-diol, oktan-1,5-diol, oktan-l,6- diol, oktan-1,7-diol, oktan-1,8-diol, oktan-2,3-diol, oktan-2,4-diol, oktan-2,5-diol, oktan-2,6-diol, oktan-2,7- diol, oktan-3,4-diol, oktan-3,5-diol, oktan-3,6-diol och oktane-4,5-diol. Det kan också vara en blandning av olika dioler såsom 2, 3, 4 eller 5 olika dioler. de olika diolerna är inte av vikt för föreliggande upp- finning, Stereokemin av och enantiomerer, diasteromerer, tautomerer och racemiska blandningar av dioler kan också användas med bra resultat. Kravet att diolerna skall vara ”olika” skall förstås att betyda att de skiljer sig med tanke på atomerna (regioisomerism) och inte på grund av om de är t.ex. R/S eller +/-.Furthermore, the diols may have a hydroxyl group on one of the diols, which is attached to different carbon atoms. Examples of diols are propane-1,2-diol, propane-1,3-diol, butane-1,2-diol, butane-1,3-diol, butane-1,4-diol, 2-methylpropane-1, 2-diol, 2-methylpropan-1,3-diol, pentane-1,2-diol, pentane-1,3-diol, pentane-1,4-diol, pentane-1,5-diol, 2-methyl- pentane-2,4-diol, pentane-2,3-diol, pentane-2,4-diol, hexane-1,2-diol, hexane-1,3-diol, hexane-1,4-diol, hexane ~ 1,5-diol, hexane-1,6-diol, hexane-2,3-diol, hexane-2,4-diol, hexane-2,5-diol, hexane-3,4-diol, heptane-1, 2-diol, heptane-1,3-diol, heptane-1,4-diol, heptane-1,5-diol, heptane-1,6-diol, heptane-1,7-diol, heptane-2,3-diol diol, heptane-2,4-diol, heptane-2,5-diol, heptane-2,6-diol, heptane-3,4-diol, heptane-3,5-diol, octane-1,2-diol, 10 15 20 25 30 35 529 906 071002 AEK 1 == \ ss9s mnbria \ s \ oia \ sz \ svar på slucförelaggivning \ z> 5s9soo14_o71oo2_1 = acent.dec 4 octane-1,3-diol, octane-1,4-diol , octane-1,5-diol, octane-1,6-diol, octane-1,7-diol, octane-1,8-diol, octane-2,3-diol, octane-2,4-diol, octane -2,5-diol, octane-2,6-diol, octane-2,7-diol, octane-3,4-diol, octane-3,5-diol, octane-3,6-diol and octane e-4,5-diol. It can also be a mixture of different diols such as 2, 3, 4 or 5 different diols. the various diols are not important to the present invention, Stereochemistry of and enantiomers, diastereomers, tautomers and racemic mixtures of diols can also be used with good results. The requirement that the diols be "different" should be understood to mean that they differ in terms of atoms (regioisomerism) and not because of whether they are e.g. R / S or +/-.
Diolen och/eller diolerna kan finnas närvarande i en mängd från ungefär 0.1 till ungefär 99 % (volym/volym) beroende på produkten i vilken diolen/diolerna används.The diol and / or diols may be present in an amount of from about 0.1 to about 99% (v / v) depending on the product in which the diol (s) is used.
Exempel på mängder är l, 10, 20, 30, 40, 50, 60, 70, 80, 90 or 99 %.Examples of amounts are 1, 10, 20, 30, 40, 50, 60, 70, 80, 90 or 99%.
Vidare kan diolerna användas tillsammans med andra komponenter såsom antibakteriella, antifungala eller antivirala komponenter, såsom antibiotika, antimykotika och antivirala medel. Exempel är penicilliner, cephalosporiner, carbacephemer, cephamyciner, carbapenemer, monobactamer, aminoglykosider, glykopeptider, quinoloner, tetracycliner, macrolider, fluoroquinoloner, imidazoler, allylaminer, acyclovir and vectavir. Exempel är antiseptiska medel omfattande jod, silver, koppar, klorhexidin, polyhexanid, alginat, zink eller zinkoxid och andra biguanider, ättiksyra och väteperoxid. Diolen kan också användas tillsammans med andra föreningar såsom naturliga, syntetiska eller semisyntetiska eller naturidentiska, som tillhandahåller doft till produkten i vilken diolen används. Exempel är olika parfymer, citrus, äpple och ros. lO 15 20 25 30 35 529 906 071002 AEK P:\5695 Ambría\P\014\SE\Svar på slutförelàggandewSö950014_0'71002_Patentvdoc Absorbent och/eller sanitetsprodukt Uppfinningen hänför och/eller sanitetsprodukt sig även till en absorbent såsom den definieras ovan, i vilken produkten omfattar åtminstone en beredning om- fattande åtminstone en diol, Diolen kan omfatta mellan 3 till 8 kolatomer i en linjär eller förgrenad kedja. Vidare kan diolen/diolerna ha hydroxigrupper på diolerna kopplade till de olika kol- atomerna. Exempel på dioler är propan-1,2-diol, propan-l,3- diol, butan-l,2-diol, butan-1,3-diol, butan-1,4-diol, 2- metylpropan-1,2-diol, 2-metylpropan -l,3-diol, pentan-1,2- diol, pentan-1,3-diol, pentan-1,4-diol, pentan-1,5-diol, 2- metyl-pentan-2,4-diol, pentan-2,3-diol, pentan-2,4-diol, hexan-1,2-diol, hexan-1,3-diol, hexan-1,4-diol, hexan-l,5- diol, hexan-1,6-diol, hexan-2,3-diol, hexan-2,4-diol, hexan-2,5-diol, hexan-3,4-diol, heptan-1,2-diol, heptan- 1,3-diol, heptan-1,4-diol, heptan-1,5-diol, heptan-l,6- diol, heptan-1,7-diol, heptan-2,3-diol, heptan-2,4-diol, heptan-2,5~diol, heptan-2,6-diol, heptan-3,4-diol, heptan- 3,5~diol, oktan-1,2-diol, oktan-1,3-diol, oktan-1,4-diol, oktan-1,5-diol, oktan-1,6-diol, oktan-1,7-diol, oktan-l,8- diol, oktan-2,3-diol, oktan-2,4-diol, oktan~2,5-diol, oktan-2,6-diol, oktan~2,7-diol, oktan-3,4-diol, oktan~3,5- diol, oktan-3,6-diol och oktan-4,5-diol. Där kan också finnas en blandning av olika dioler såsom 2, 3, 4 eller 5 dioler. Stereokemin av de olika diolerna är inte av vikt för föreliggande uppfinning, och enantiomerer, diastero- merer, tautomerer och racemiska blandningar av dioler kan också användas med bra resultat. Kravet att diolerna skall vara ”olika” skall förstås att betyda att de skiljer sig med tanke på atomerna (regioisomerism) och inte på grund av R/S eller +/~.Furthermore, the diols can be used together with other components such as antibacterial, antifungal or antiviral components, such as antibiotics, antifungals and antiviral agents. Examples are penicillins, cephalosporins, carbacephemes, cephamycins, carbapenems, monobactams, aminoglycosides, glycopeptides, quinolones, tetracyclines, macrolides, fluoroquinolones, imidazoles, allylamines, acyclovir and vectavir. Examples are antiseptics comprising iodine, silver, copper, chlorhexidine, polyhexanide, alginate, zinc or zinc oxide and other biguanides, acetic acid and hydrogen peroxide. The diol can also be used in conjunction with other compounds such as natural, synthetic or semi-synthetic or nature-identical, which provide fragrance to the product in which the diol is used. Examples are different perfumes, citrus, apple and rose. The invention relates to / and sanitary product also to an absorbent as defined above, in which the product comprises at least one formulation comprising at least one diol. The diol may comprise between 3 to 8 carbon atoms in a linear or branched chain. Furthermore, the diol (s) may have hydroxy groups on the diols attached to the various carbon atoms. Examples of diols are propane-1,2-diol, propane-1,3-diol, butane-1,2-diol, butane-1,3-diol, butane-1,4-diol, 2-methylpropane-1, 2-diol, 2-methylpropane-1,3-diol, pentane-1,2-diol, pentane-1,3-diol, pentane-1,4-diol, pentane-1,5-diol, 2-methyl- pentane-2,4-diol, pentane-2,3-diol, pentane-2,4-diol, hexane-1,2-diol, hexane-1,3-diol, hexane-1,4-diol, hexane 1,5-diol, hexane-1,6-diol, hexane-2,3-diol, hexane-2,4-diol, hexane-2,5-diol, hexane-3,4-diol, heptane-1, 2-diol, heptane-1,3-diol, heptane-1,4-diol, heptane-1,5-diol, heptane-1,6-diol, heptane-1,7-diol, heptane-2,3- diol, heptane-2,4-diol, heptane-2,5-diol, heptane-2,6-diol, heptane-3,4-diol, heptane-3,5-diol, octane-1,2-diol, octane-1,3-diol, octane-1,4-diol, octane-1,5-diol, octane-1,6-diol, octane-1,7-diol, octane-1,8-diol, octane- 2,3-diol, octane-2,4-diol, octane-2,5-diol, octane-2,6-diol, octane-2,7-diol, octane-3,4-diol, octane-3, 5-diol, octane-3,6-diol and octane-4,5-diol. There may also be a mixture of different diols such as 2, 3, 4 or 5 diols. The stereochemistry of the various diols is not important to the present invention, and enantiomers, diastereomers, tautomers and racemic mixtures of diols may also be used with good results. The requirement that the diols be "different" should be understood to mean that they differ in terms of atoms (regioisomerism) and not because of R / S or + / ~.
Diolen och/eller diolerna kan finnas närvarande i en mängd från ungefär 0.1 till ungefär 99 % om de är t.ex. (volym/Volym) 10 15 20 25 30 529 906 071002 AEK 1>=\ss9s Anwbria\v\oia\ss\svaz på slucfórelàggandewssssooigovloozjacen:.dec beroende pà produkten i vilken diolen/diolerna används.The diol and / or diols may be present in an amount of from about 0.1 to about 99% if they are e.g. (volume / Volume) 10 15 20 25 30 529 906 071002 AEK 1> = \ ss9s Anwbria \ v \ oia \ ss \ svaz on slucforelàggandewssssooigovloozjacen: .dec depending on the product in which the diol / diols are used.
Exempel på mängder är l, 10, 20, 30, 40, 50, 60, 70, 80, 90 or 99 %.Examples of amounts are 1, 10, 20, 30, 40, 50, 60, 70, 80, 90 or 99%.
Vidare kan diolerna användas tillsammans med andra komponenter såsom antibakteriella, antifungala eller antivirala komponenter, såsom antibiotika, antimykotika och antivirala medel. Exempel är penicilliner, cephalosporiner, carbacephemer, cephamyciner, carbapenemer, monobactamer, aminoglykosider, glykopeptider, quinoloner, tetracycliner, macrolider, fluoroquinoloner, imidazoler, allylaminer, acyclovir and vectavir. Exempel är antiseptiska medel omfattande jod, silver, koppar, klorhexidin, polyhexanid, alginat, zink eller zinkoxid och andra biguanider, ättiksyra och väteperoxid. Diolen kan också användas tillsammans med andra föreningar såsom naturliga, syntetiska eller semisyntetiska eller naturidentiska, som tillhandahåller doft till produkten i vilken diolen används. Exempel är olika parfymer, citrus, äpple och ros.Furthermore, the diols can be used together with other components such as antibacterial, antifungal or antiviral components, such as antibiotics, antifungals and antiviral agents. Examples are penicillins, cephalosporins, carbacephemes, cephamycins, carbapenems, monobactams, aminoglycosides, glycopeptides, quinolones, tetracyclines, macrolides, fluoroquinolones, imidazoles, allylamines, acyclovir and vectavir. Examples are antiseptics comprising iodine, silver, copper, chlorhexidine, polyhexanide, alginate, zinc or zinc oxide and other biguanides, acetic acid and hydrogen peroxide. The diol can also be used in conjunction with other compounds such as natural, synthetic or semi-synthetic or nature-identical, which provide fragrance to the product in which the diol is used. Examples are different perfumes, citrus, apple and rose.
Absorbenten och/eller sanitetsprodukten kan vara någon absorbent eller sanitetsprodukt, så länge som produkten vid användningen tillhandahåller nya egenskaper för att minska och/eller eliminera odör från däggdjurs~ vätskor såsom människo- eller djurvätskor. Exempel är engångsabsorberande skikt, luftuppfriskande produkter, bindor, underplaggs-vaderingar, tamponger, bandage, kompresser, ansiktsmasker, luftfiltreringsmedel, sanitetsbindor, tamponger, trosskydd, inkontinensskydd, inkontinensmedel, kirurgiska kläder, självhäftande bandage, en pappersprodukt innehållande en eller flera pappersskikt, såsom ansiktsservetter, pappershanddukar, toalettpapper och näsdukar.The absorbent and / or sanitary product may be any absorbent or sanitary product, as long as the product in use provides new properties to reduce and / or eliminate odors from mammalian fluids such as human or animal fluids. Examples are disposable absorbent layers, air fresheners, sanitary napkins, pads, tampons, bandages, compresses, face masks, air filters, sanitary napkins, tampons, pantiliners, incontinence guards, incontinence agents, surgical garments, self-adhesive multi-adhesive paper tape, , paper towels, toilet paper and handkerchiefs.
Uppfinningen hänför sig också till förpackningar omfattande en eller flera absorbent och/eller sanitets- artiklar såsom definieras ovan. 10 15 20 25 30 35 529 906 071902 AEK P:\5695 Anbria\P\0l4\SE\Svar på slutförelàggande\P5S950014_07l002_Patent.doc Uppfinningen hänför sig också till en metod för framställning av en absorbent och/eller sanitetsprodukt såsom den definieras ovan.The invention also relates to packages comprising one or more absorbent and / or sanitary articles as defined above. The invention also relates to a method for producing an absorbent and / or sanitary product as defined above.
Följande exempel är meningen att illustrera men inte begränsa uppfinningen på något sätt, form eller utförande, varken explicit eller implicit.The following examples are intended to illustrate but not limit the invention in any way, form or embodiment, either explicitly or implicitly.
EXEMPEL Exempel l Aktiva lösningar innehållande 10 % (volym/volym) 0Ch 30 % (volym/volym) pentan-1,5-diol sprayades på en engàngsnäsduk tills hela ytan av näsduken var fuktig.EXAMPLES Example 1 Active solutions containing 10% (v / v) or 30% (v / v) pentane-1,5-diol were sprayed onto a disposable handkerchief until the entire surface of the handkerchief was moist.
Näsduken lämnades vid rumstemperatur tills den var torr.The handkerchief was left at room temperature until dry.
Näsduken användes sedan för att ta bort urin från en människa. Efter att man hade tagit bort urin med hjälp av näsduken, fann man att det inte fanns någon lukt av urin från näsduken, vilket var behagligt för användaren av näsduken.The handkerchief was then used to remove urine from a human. After removing urine using the handkerchief, it was found that there was no odor of urine from the handkerchief, which was pleasant for the user of the handkerchief.
Som en kontroll användes enbart vatten. Samma mängd av vatten och den aktiva beredningen användes.As a control, only water was used. The same amount of water and the active preparation were used.
Exempel 2 Den samma lösningen som i exempel 1 sprayades på en dambinda tills hela bindan täcktes av lösningen. Bindan lämnades i rumstemperatur tills den hade torkat. Vid användandet av bindan av en kvinna med urinläckageproblem, kunde man inte upptäcka någon lukt även efter en lång användningsperiod.Example 2 The same solution as in Example 1 was sprayed on a sanitary napkin until the entire napkin was covered by the solution. The napkin was left at room temperature until it had dried. When using the bandage of a woman with urine leakage problems, no odor could be detected even after a long period of use.
Exempel 3 Kompresser sprayades på samma sätt och_med samma lösning som i Exempel l. 10 15 20 25 529 906 onooz AEK P=\5s9s Anmria\1=\o1§\sz\svar pà slucfórelàggandewss9sou14_o11oo2_Patent.doc Exemgel 4 Kompresser sprayades på samma sätt och med samma lösning som i Exempel 1. En sådan kompress kan sedan användas som en kompress att anbringas på ett sår, såsom ett bensår eller dekubitalt sår.Example 3 Compresses were sprayed in the same manner and with the same solution as in Example 1. 10 15 20 25 529 906 onooz AEK P = with the same solution as in Example 1. Such a compress can then be used as a compress to be applied to a wound, such as a leg wound or decubital wound.
Claims (6)
Priority Applications (15)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0502610A SE529906C2 (en) | 2005-11-29 | 2005-11-29 | Use of composition comprising pentane-1,5-diol to reduce and/or eliminate odor obtained from urine, faeces, liquids from leg ulcers, decubital ulcers, blood, menstruation and perspiration |
KR1020087012786A KR20080080508A (en) | 2005-11-29 | 2006-11-28 | Use of a composition comprising pentane-1,5-diol as deodorant |
ES06830157.1T ES2621125T3 (en) | 2005-11-29 | 2006-11-28 | Use of an absorption product comprising 1,5-pentanediol as a deodorant |
CNA2006800440734A CN101316508A (en) | 2005-11-29 | 2006-11-28 | Use of a composition comprising pentane-1, 5-diol as deodorant |
BRPI0619367A BRPI0619367A2 (en) | 2005-11-29 | 2006-11-28 | absorption product, and method of manufacture thereof |
JP2008542748A JP2009517152A (en) | 2005-11-29 | 2006-11-28 | Use of a composition comprising pentane-1,5-diol as a deodorant |
US12/085,582 US20090232761A1 (en) | 2005-11-29 | 2006-11-28 | Use of a Composition Comprising Pentane-1, 5-Diol as Deodorant |
AU2006319206A AU2006319206A1 (en) | 2005-11-29 | 2006-11-28 | Use of a composition comprising pentane-1, 5-diol as deodorant |
PL06830157T PL1956903T3 (en) | 2005-11-29 | 2006-11-28 | Use of an absorption product comprising pentane-1, 5-diol as deodorant |
EP06830157.1A EP1956903B1 (en) | 2005-11-29 | 2006-11-28 | Use of an absorption product comprising pentane-1, 5-diol as deodorant |
CA002630881A CA2630881A1 (en) | 2005-11-29 | 2006-11-28 | Use of a composition comprising pentane-1, 5-diol as deodorant |
RU2008126267/15A RU2455027C2 (en) | 2005-11-29 | 2006-11-28 | Use of composition containing pentane-1,5-diol as deodorant |
PCT/EP2006/069007 WO2007063065A1 (en) | 2005-11-29 | 2006-11-28 | Use of a composition comprising pentane-1, 5-diol as deodorant |
JP2014076011A JP2014210173A (en) | 2005-11-29 | 2014-04-02 | Use of composition including pentane-1,5-diol as deodorant |
JP2015214004A JP6149088B2 (en) | 2005-11-29 | 2015-10-30 | Use of a composition comprising pentane-1,5-diol as a deodorant |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0502610A SE529906C2 (en) | 2005-11-29 | 2005-11-29 | Use of composition comprising pentane-1,5-diol to reduce and/or eliminate odor obtained from urine, faeces, liquids from leg ulcers, decubital ulcers, blood, menstruation and perspiration |
Publications (2)
Publication Number | Publication Date |
---|---|
SE0502610L SE0502610L (en) | 2007-05-30 |
SE529906C2 true SE529906C2 (en) | 2007-12-27 |
Family
ID=38175544
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE0502610A SE529906C2 (en) | 2005-11-29 | 2005-11-29 | Use of composition comprising pentane-1,5-diol to reduce and/or eliminate odor obtained from urine, faeces, liquids from leg ulcers, decubital ulcers, blood, menstruation and perspiration |
Country Status (5)
Country | Link |
---|---|
CN (1) | CN101316508A (en) |
BR (1) | BRPI0619367A2 (en) |
ES (1) | ES2621125T3 (en) |
PL (1) | PL1956903T3 (en) |
SE (1) | SE529906C2 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2018157936A1 (en) * | 2017-03-02 | 2018-09-07 | Essity Hygiene And Health Aktiebolag | Wipe with skin beneficial effect |
CN107261186A (en) * | 2017-07-28 | 2017-10-20 | 威海洁瑞医用制品有限公司 | Suppress or absorb the hydrocolloid material and medical dressing and its preparation method of peculiar smell |
CN108567579B (en) * | 2018-07-27 | 2021-08-03 | 广州世航生物科技有限公司 | Preservative composition and use thereof |
-
2005
- 2005-11-29 SE SE0502610A patent/SE529906C2/en unknown
-
2006
- 2006-11-28 CN CNA2006800440734A patent/CN101316508A/en active Pending
- 2006-11-28 ES ES06830157.1T patent/ES2621125T3/en active Active
- 2006-11-28 BR BRPI0619367A patent/BRPI0619367A2/en not_active IP Right Cessation
- 2006-11-28 PL PL06830157T patent/PL1956903T3/en unknown
Also Published As
Publication number | Publication date |
---|---|
SE0502610L (en) | 2007-05-30 |
CN101316508A (en) | 2008-12-03 |
PL1956903T3 (en) | 2017-07-31 |
ES2621125T3 (en) | 2017-07-03 |
BRPI0619367A2 (en) | 2017-06-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2455027C2 (en) | Use of composition containing pentane-1,5-diol as deodorant | |
US6972010B2 (en) | Absorbent article comprising an agent able to convey a perception to the wearer, without the need to create the external condition perceived | |
AU2002254624B8 (en) | An absorbent article comprising an agent able to convey a perception to the wearer | |
US20040081680A1 (en) | Articles comprising a mint odor-free cooling agent | |
AU2002254624A1 (en) | An absorbent article comprising an agent able to convey a perception to the wearer | |
US20120226248A1 (en) | Absorbent article comprising cyclodextrin complex | |
CN108992252A (en) | A kind of amenities containing quick-fried pearl | |
US10653811B2 (en) | Articles with odor-controlling composition | |
US20120157946A1 (en) | Absorbent article comprising cyclodextrin complex | |
CA2442626A1 (en) | Articles comprising a mint odor-free cooling agent | |
KR20040030586A (en) | Cooling compositions | |
SE529906C2 (en) | Use of composition comprising pentane-1,5-diol to reduce and/or eliminate odor obtained from urine, faeces, liquids from leg ulcers, decubital ulcers, blood, menstruation and perspiration | |
CN1189219C (en) | Absorption article containing cyclo dextrin | |
EP3256088B1 (en) | Articles with odor-controlling composition | |
CN205031436U (en) | Magnetism anion sanitary towel alive | |
CN114222553A (en) | Personal hygiene product | |
CN112618776A (en) | Sanitary towel with peculiar smell inhibiting function | |
MX2008006803A (en) | Use of a composition comprising pentane-1, 5-diol as deodorant | |
CN208926818U (en) | A kind of amenities containing quick-fried pearl | |
KR200362585Y1 (en) | a Nano silver combination hygienic band, a sanitary napkin | |
KR20040088009A (en) | a Nano silver combination hygienic band, a sanitary napkin |